Literature DB >> 16108773

Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece.

S P Savvas1, J Koskinas, C Sinani, A Hadziyannis, F Spanou, S J Hadziyannis.   

Abstract

SUMMARY: The aim of this study was to investigate the relative frequency of hepatitis C virus (HCV) genotypes in Greek patients with chronic infection as well as possible secular changes in their distribution in relation to modes of transmission, age and time at acquisition of the infection and other variables. We evaluated 434 unselected patients, 241 males and 193 females with a median age of 46.2 years (18-75), with chronic HCV infection presenting during the period 1996-2000. HCV infection was confirmed by the detection of HCV-RNA by polymerase chain reaction (PCR), while HCV genotyping was performed by the Inno-LiPA assay. Liver biopsies were evaluated according to Ishak's scoring system. Of 434 patients, 167 had a history of blood transfusion [post-transfusion hepatitis (PTH)], 80 were i.v. drug users and in 187 the route of infection remained unknown. The overall distribution of HCV genotypes 1, 2, 3 and 4 was 47, 8.3, 27 and 15.2%, respectively. Genotype 3 was common in younger adults and i.v. drug users, whereas genotype 1 predominated in older people and PTH patients (P < 0.001 for both). Infection acquired before 1981 (group A) was related to transfusion and genotype 1, while after 1981 (group B) with i.v. drug use and genotype 3 (P < 0.01). Biopsy was available in 369 (85%) patients, of whom 22.5% had cirrhosis; 29.8% in group A and 9.9% in group B. In a multivariate analysis, cirrhosis was strongly associated with the duration of infection (P = 0.013). Our study revealed a change of HCV genotype distribution in the last 20 years among Greek patients with chronic HCV infection as a result of epidemiological changes in HCV transmission. The presence of cirrhosis was associated only with the duration of infection. These observations have impact both on prevention and treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16108773     DOI: 10.1111/j.1365-2893.2005.00614.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  14 in total

1.  Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study.

Authors:  O Anagnostou; S Manolakopoulos; G Bakoyannis; G Papatheodoridis; A Zisouli; M Raptopoulou-Gigi; E Manesis; I Ketikoglou; G Dalekos; C Gogos; T Vassiliadis; D Tzourmakliotis; S Karatapanis; S Kanatakis; - Zoumpoulis; A Hounta; S Koutsounas; G Giannoulis; N Tassopoulos; G Touloumi
Journal:  Hippokratia       Date:  2014-01       Impact factor: 0.471

2.  HCV genotype distribution and possible transmission risks in Lahore, Pakistan.

Authors:  Waqar Ahmad; Bushra Ijaz; Fouzia-Tahir Javed; Shah Jahan; Imran Shahid; Fawad-Mumtaz Khan; Sajida Hassan
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

3.  Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study.

Authors:  M Raptopoulou; G Touloumi; D Tzourmakliotis; G Nikolopoulou; M Dimopoulou; G Giannoulis; T Vasiliadis; A Skoutelis; O Anagnostou; G Hatzis; S Manolakopoulos
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

4.  Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance.

Authors:  Neda Svirtlih; Dragan Delic; Jasmina Simonovic; Djordje Jevtovic; Ljubisa Dokic; Eleonora Gvozdenovic; Ivan Boricic; Dragic Terzic; Sladjana Pavic; Gorana Neskovic; Sonja Zerjav; Vladimir Urban
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

5.  Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006.

Authors:  Francois Roman; Karin Hawotte; Daniel Struck; Anne-Marie Ternes; Jean-Yves Servais; Vic Arendt; Patrick Hoffman; Robert Hemmer; Therese Staub; Carole Seguin-Devaux; Jean-Claude Schmit
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

6.  Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china.

Authors:  Zehui Yan; Ke Fan; Yuming Wang; Yi Fan; Zhaoxia Tan; Guohong Deng
Journal:  Hepat Mon       Date:  2012-03-28       Impact factor: 0.660

7.  Determining major genotypes of hepatitis C virus among transplant recipients by real-time polymerase chain reaction assay.

Authors:  Roya Feyznezhad; Mohammad Amin Behzadi; Ramin Yaghobi; Mazyar Ziyaeyan
Journal:  Jundishapur J Microbiol       Date:  2015-02-20       Impact factor: 0.747

8.  The phylogenetic analysis of hepatitis C virus isolates obtained from two Iranian carriers revealed evidence for a new subtype of HCV genotype 3.

Authors:  Safieh Amini; Malek-Hossein Ahmadi Pour; Kayhan Azadmanesh
Journal:  Virus Genes       Date:  2006-12       Impact factor: 2.332

Review 9.  Epidemiological features and specificities of HCV infection: a hospital-based cohort study in a university medical center of Calabria region.

Authors:  M C Liberto; N Marascio; E Zicca; G Matera
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

10.  Distribution of hepatitis C virus genotypes in Iranian chronic infected patients.

Authors:  Fatemeh Jahanbakhsh Sefidi; Hossein Keyvani; Seyed Hamidreza Monavari; Seyed Moayed Alavian; Shahin Fakhim; Farah Bokharaei-Salim
Journal:  Hepat Mon       Date:  2013-01-20       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.